442526-91-2

Usage

Uses

Used in Coatings Industry:
DFSX-2 is used as a surfactant and dispersing agent for enhancing the wetting and spreading properties of coatings, ensuring even distribution and improved adhesion to surfaces.
Used in Adhesives Industry:
DFSX-2 is utilized as a component in adhesive formulations to improve the wetting of adhesives on various substrates, leading to stronger bonds and better overall performance.
Used in Cleaning Products Industry:
DFSX-2 serves as a key ingredient in cleaning products, where its ability to lower surface tension aids in the more efficient removal of dirt and stains.
Used in Agricultural Pesticides:
DFSX-2 is employed as a surfactant in the formulation of agricultural pesticides to improve the wetting and spreading of the pesticide on plant surfaces, ensuring more effective pest control.
Used in Oil Drilling and Extraction Industry:
DFSX-2 is used in oil drilling and extraction processes to enhance the wetting and dispersion of drilling muds and other substances, facilitating more efficient extraction of oil and reducing the risk of wellbore instability.

Upstream product

• 97-72-3 2-Methylpropionic anhydride 
• 906088-96-8 C₁₇H₁₁F₄N₃O₃ 
• 18621-18-6 azetion-3-ol hydrochloride 
• 247069-27-8 2,6-diamino-3,5-difluoropyridine 
• 101799-75-1 α-(ethoxymethylene)-2,4,5-trifluoro-β-oxobenzenepropanoic acid, ethyl ester 
• 77-92-9 citric acid 
• 98349-24-7 ethyl 2,4,5-trifluorobenzoylacetate 
• 88419-56-1 2,4,5-trifluorobenzoyl chloride 
• 446-17-3 2,4,5-trifluorobenzoic acid 
• 875712-88-2 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-isobutyryloxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 
• 1468-39-9 Isovaleric anhydride 

Downstream Products

• 352458-37-8 1-(6-amino-3,5-difluoro-2-pyridinyl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-hydroxy-1-azetidinyl)-4-oxo-3-quinolinecarboxylic acid 1-deoxy-1-(methylamino)-D-glucitol 
• 189279-58-1 delafloxacin 

Relevant academic research and scientific papers

Refining method of ciprofloxacin and meglumine hydrochloride thereof

The invention provides a preparation process of ciprofloxacin and meglumine thereof. The intermediate product DLSX07 is stirred at Branson ° C. 20% minutes and then sonicated until the solution is cloudy, stirred at room temperature for a period 30s, stirred at room temperature 3h, cooled and slowly added to distilled water, and filtered through suction filtration and filter cake vacuum drying to obtain a pale yellow powder, and 4% the KOH mixture is subjected to ultrasonic treatment 40 - 50 °C. 1. The process is performed by stirring 5h. NCS .t. The solution is cloudy. LC-MS / MS detection powder is deltafloxacin, distilled water is added, and meglumine is mixed to obtain a deltafloxacin meglumine salt. By optimizing the preparation process, the use of the organic solvent is reduced, the reaction time is shortened, and the ice bath and the addition of the interface carrier material contribute to the improvement of the yield.

A kind of improved [...] preparation method (by machine translation)

The invention belongs to the field of medical synthesis, in particular to a kind of improved [...] preparation method. The technology of this invention can avoid a 4 - benzopyran [...] formation of impurities, and follow-up substituted, cyclized, butt joi

Preparation of deller floxacin and intermediate thereof

The invention relates to preparation of deller floxacin and an intermediate thereof. According to the preparation method of the deller floxacin, the purity of an intermediate compound, a compound A-3and a compound W-4 is limited to be more than 99.0 perce

Chlorination at the 8-position of a functionalized quinolone and the synthesis of quinolone antibiotic ABT-492

The total synthesis of quinolone antibiotic ABT-492 has been achieved in 67% yield over nine steps from 2,4,5-trifluorobenzoic acid. The highlights of this synthesis include a novel chemoselective chlorination at the 8-position of a highly elaborated quinolone core. In addition, a Lewis acid promoted cyclization reaction to form the quinolone heterocycle was developed which was incorporated into a one-pot, three-step cyclization/coupling/protection sequence that proceeds in 93% yield.

Synthesis of the quinolone ABT-492: Crystallizations for optimal processing

ABT-492 has been under development at Abbott Laboratories as a quinolone antibiotic. A convergent syntheses was utilized to prepare the compound on a multi-kilogram scale. Difficulties in isolation of intermediates were overcome by developing control of t

PREPARATION OF PYRIDONECARBOXYLIC ACID ANTIBACTERIALS

A process for making 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid, and therapeutically acceptable salts thereof, and intermediates used in the process are disclosed.